Salta al contenuto
VuFind
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文(繁體)
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
Հայերէն
Українська
Sámegiella
Монгол
Lingua
Tutti i Campi
Titolo
Autore
Soggetto
Collocazione
ISBN/ISSN
Tag
Cerca
Avanzata
Detection of broad functional...
Citazione
Invia SMS
Invia email
Stampa
Esporta il record
Esporta a RefWorks
Esporta a EndNoteWeb
Esporta a EndNote
PLink permanente
Detection of broad functional gag-specific CD4+T cell responses in HIV-1-infected subjects following therapeutic immunization with rMVA expressing an HIV-1 gag immunogen
Dettagli Bibliografici
Autori principali:
Ondondo, B
,
Yang, H
,
Dong, T
,
de Gleria, K
,
Suttill, A
,
Conlon, C
,
Brown, D
,
Williams, P
,
Bowness, P
,
Rowland-Jones, S
,
Hanke, T
,
McMichael, A
,
Dorrell, L
Natura:
Journal article
Pubblicazione:
2006
Posseduto
Descrizione
Documenti analoghi
MARC21
Documenti analoghi
Detection of broad functional gag-specific CD4+ T cell responses in HIV-1-infected subjects following therapeutic immunization with rMVA expressing an HIV-1 gag immunogen
di: Rowland-Jones Sarah L, et al.
Pubblicazione: (2006-12-01)
Immunisation with recombinant modified vaccinia virus Ankara expressing HIV-1 gag in HIV-1-infected subjects stimulates broad functional CD4+ T cell responses.
di: Ondondo, B, et al.
Pubblicazione: (2006)
Safety and tolerability of recombinant modified vaccinia virus Ankara expressing an HIV-1 gag/multiepitope immunogen (MVA.HIVA) in HIV-1-infected persons receiving combination antiretroviral therapy.
di: Dorrell, L, et al.
Pubblicazione: (2007)
Expansion and diversification of virus-specific T cells following immunization of human immunodeficiency virus type 1 (HIV-1)-infected individuals with a recombinant modified vaccinia virus Ankara/HIV-1 Gag vaccine.
di: Dorrell, L, et al.
Pubblicazione: (2006)
Therapeutic immunization of highly active antiretroviral therapy-treated HIV-1-infected patients: safety and immunogenicity of an HIV-1 gag/poly-epitope DNA vaccine.
di: Dorrell, L, et al.
Pubblicazione: (2005)